Itus Stock Buy Or Sell Official
The ticker formerly represented ITUS Corporation, which underwent a name change and rebranding to Anixa Biosciences (ANIX) in 2018. Analysts currently view ANIX as a high-potential but high-risk biotech play, with a consensus rating of Strong Buy from multiple firms as of April 2026. Anixa Biosciences (ANIX) Financial Snapshot Buy/Sell Analysis
: The average 12-month price target is approximately $10.00 , representing a potential upside of over 220% from its current price near $3.05. itus stock buy or sell
: Major firms like Zacks Investment Research and MarketBeat report a consensus "Strong Buy" or "Buy" rating. : Major firms like Zacks Investment Research and
: Some technical analysis platforms like StockInvest.us have recently downgraded the stock to a Hold candidate due to short-term technical weaknesses and high volatility. Key Considerations ANIX Stock Quote Price and Forecast | CNN The ticker formerly represented ITUS Corporation
![The Night Manager S02 [SERIE TV - 2160PO - ATMOS 7.1]](https://image.over-blog.com/mUEGPcFDkQMqFtNv5K3uUEZwnrk=/400x260/smart/filters:no_upscale()/image%2F0517715%2F20260125%2Fob_2fbbd2_a6abc8663d73aa363cb454e662bb9060caee41.jpg)
![Les Gouttes de Dieu S02 [SERIE TV - 2160P - ATMOS 5.1]](https://image.over-blog.com/rLK4Rk31qwfZNUiggdLeM_fRdv8=/400x260/smart/filters:no_upscale()/image%2F0517715%2F20260125%2Fob_5a9259_sans-titre.png)
![A Knight of the Seven Kingdoms S01 [SERIE TV - 2160P - ATMOS 7.1]](https://image.over-blog.com/y7EW5R-uC0sh3K649tVmImKJFR4=/400x260/smart/filters:no_upscale()/image%2F0517715%2F20260125%2Fob_2f7d1e_a-knight-of-the-seven-kingdoms.png)
/image%2F0517715%2F20251227%2Fob_055f06_5f20c639-0246-4b32-bee0-d5eeb8320ddd.png)
